Addressing FDA Regulatory Barriers to AI in Clinical Care
3 Articles
3 Articles
Addressing FDA regulatory barriers to AI in clinical care
A version of the following public comment letter was submitted to the Department of Health and Human Services on February 23, 2026. On behalf of Reason Foundation, we respectfully submit these comments in response to the request for information (“RFI”) on Accelerating the Adoption and Use of Artificial Intelligence as Part of Clinical Care published by the Office of the Deputy Secretary and Assistant Secretary for Policy (ASTP) and Office of the…
AHA responds to HHS RFI on AI in clinical care
The AHA responded to a request for information today from the Department of Health and Human Services on the adoption and use of artificial intelligence in clinical care. The AHA urged HHS to synchronize and leverage existing AI policy frameworks to avoid redundancy, remove regulatory barriers that inhibit the development and deployment of AI tools, adopt policies ensuring the safe and effective use of AI, and align incentives and address infras…
Alliance Submits Comments in Response to HHS's Request for Information on Accelerating the Adoption and Use of Artificial Intelligence as Part of Clinical Care
Members get unlimited access to the latest resources, news, and policy updates at the National Alliance for Care at Home. You must be a member of the National Alliance for Care at Home to access this content. Log In Now Create an Account Not a member? Join a network of dedicated professionals like yourself today. Become a Member The post Alliance Submits Comments in Response to HHS’s Request for Information on Accelerating the Adoption and U…
Coverage Details
Bias Distribution
- 100% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium

